Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Chemotherapy often causes skin, hair, and nail problems in cancer patients.

Alkylating agents can kill cancer cells but may cause skin and allergic reactions.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Erlotinib can cause hair loss as a side effect.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Aromatase inhibitors can cause various adverse reactions, so monitoring is crucial.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

Catalase in processed meats may increase cancer risk due to electromagnetic emissions.

Icariside II may help treat gastric cancer by stopping tumor growth.

Minocycline reduces acne rash, pyridoxine lowers hand-foot syndrome risk, and scalp cooling lessens hair loss from cancer treatments.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

Anti-androgen therapy is crucial for treating cancer and hormone-related diseases, even with low testosterone levels.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

The link between anabolic agents and colorectal cancer risk is unclear.

Radiation cystitis patients need better monitoring and early treatment due to higher readmission rates.

Some drugs for inflammation may cause psoriasis-like hair loss.

Taking 5-alpha reductase inhibitors might be linked to breast cancer in men.

Chemotherapy-induced hair loss may be linked to immune system changes, and certain treatments could help but need careful use.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

A new method helps manage skin side effects from hormonal cancer therapy, improving patient care.

Most pediatric cancer patients at Muhimbili National Hospital in Tanzania experienced side effects from chemotherapy, with nausea, hair loss, and low white blood cell count being the most common.

Lung cancer patients on immunotherapy and chemotherapy often experience severe fatigue, drowsiness, and appetite loss.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Later line chemotherapy causes severe side effects, impacting quality of life, but patients continue treatment to extend life and stay connected with loved ones.

Gefitinib treatment led to unexpected hair growth in two lung cancer patients.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

The case shows the importance of quick and thorough evaluation of adrenal tumors to prevent rapid disease progression and poor outcomes.